- Home
- OKYO vs RMTI Comparison
OKYO vs RMTI Comparison
Compare OKYO & RMTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OKYO
- RMTI
- Stock Information
- Founded
- OKYO 2007
- RMTI 1994
- Country
- OKYO United Kingdom
- RMTI United States
- Employees
- OKYO N/A
- RMTI N/A
- Industry
- OKYO Biotechnology: Biological Products (No Diagnostic Substances)
- RMTI Biotechnology: Pharmaceutical Preparations
- Sector
- OKYO Health Care
- RMTI Health Care
- Exchange
- OKYO Nasdaq
- RMTI Nasdaq
- Market Cap
- OKYO 37.0M
- RMTI 33.0M
- IPO Year
- OKYO 2022
- RMTI 1998
- Fundamental
- Price
- OKYO $1.85
- RMTI $0.98
- Analyst Decision
- OKYO Strong Buy
- RMTI Strong Buy
- Analyst Count
- OKYO 1
- RMTI 2
- Target Price
- OKYO $7.00
- RMTI $4.00
- AVG Volume (30 Days)
- OKYO 198.3K
- RMTI 261.1K
- Earning Date
- OKYO 06-06-2025
- RMTI 05-12-2025
- Dividend Yield
- OKYO N/A
- RMTI N/A
- EPS Growth
- OKYO N/A
- RMTI N/A
- EPS
- OKYO N/A
- RMTI N/A
- Revenue
- OKYO N/A
- RMTI $97,727,000.00
- Revenue This Year
- OKYO N/A
- RMTI N/A
- Revenue Next Year
- OKYO N/A
- RMTI $10.35
- P/E Ratio
- OKYO N/A
- RMTI N/A
- Revenue Growth
- OKYO N/A
- RMTI 12.82
- 52 Week Low
- OKYO $0.81
- RMTI $0.86
- 52 Week High
- OKYO $1.98
- RMTI $5.15
- Technical
- Relative Strength Index (RSI)
- OKYO 62.66
- RMTI 42.27
- Support Level
- OKYO $1.70
- RMTI $0.95
- Resistance Level
- OKYO $1.98
- RMTI $1.09
- Average True Range (ATR)
- OKYO 0.18
- RMTI 0.07
- MACD
- OKYO 0.03
- RMTI -0.00
- Stochastic Oscillator
- OKYO 80.30
- RMTI 18.72
About OKYO OKYO Pharma Limited
OKYO Pharma Ltd is a biopharmaceutical company. The company is developing therapeutics to improve the lives of patients with inflammatory eye diseases and chronic pain. It offers solutions for various diseases such as Dry Eye Disease, Non-infectious Anterior Uveitis, Allergenic Conjunctivitis, Chronic Pain, and Ocular Pain.
About RMTI Rockwell Medical Inc.
Rockwell Medical Inc is a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers. It is a supplier of liquid bicarbonate concentrates, and acid and dry bicarbonate concentrates for dialysis patients in the United States. The company's products include CitraPure citric acid concentrate, RenalPure liquid acid concentrate, and SteriLyte bicarbonate concentrate among others.